Roche has won the behind-the-scenes auction for InterMune ($ITMN) and its late-stage drug for idiopathic pulmonary fibrosis, announcing Sunday that it is buying up the U.S. biotech for $8.3 billion.
罗氏赢得了背后的幕后拍卖InterMune公司($ ITMN)和后期的药物治疗特发性肺间质纤维化,宣布周日是收购美国生物科技美元83亿。 作者: 高高山顶立 时间: 2014-8-26 21:41